Citation 167209

XU,YT: DU,CZ: ZHANG,FR: JI,XJ:. (1981). THE EFFECT OF HARRINGTONINE AND ITS ALLIED ALKALOIDS ON THE INCORPORATION OF LABELED AMINO ACIDS INTO PROTEINS OF CELLS OF TRANSPLANTABLE LEUKEMIAS L-615 AND P-388.. 16(9)

Citation Details

Title	THE EFFECT OF HARRINGTONINE AND ITS ALLIED ALKALOIDS ON THE INCORPORATION OF LABELED AMINO ACIDS INTO PROTEINS OF CELLS OF TRANSPLANTABLE LEUKEMIAS L-615 AND P-388.
Authors	XU,YT: DU,CZ: ZHANG,FR: JI,XJ:
Year	1981
Volume	16
Issue	9

Summary

Year: 1981

Journal: Unknown

Organisms and Their Experiments (4)

Unknown organism

Experiment #	Pharmacology Type	Worktypes	Compound	Results
1	ANTITUMOR ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VIVOANTICANCER AND/OR CYTOTOXICITY MARKER CODE	HARRINGTONINE	INACTIVE
2	ANTITUMOR ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VIVOANTICANCER AND/OR CYTOTOXICITY MARKER CODE	HARRINGTONINE	INACTIVE
3	ANTITUMOR ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VIVOANTICANCER AND/OR CYTOTOXICITY MARKER CODE	HARRINGTONINE	INACTIVE
4	PROTEIN SYNTHESIS INHIBITION	PHARMACOLOGY OF COMPOUND - IN VIVO	HARRINGTONINE	ACTIVE
5	PROTEIN SYNTHESIS INHIBITION	PHARMACOLOGY OF COMPOUND - IN VIVO	HARRINGTONINE	ACTIVE
6	TOXICITY ASSESSMENT(QUANTITATIVE)	TOXICITY MARKER CODEPHARMACOLOGY OF COMPOUND - IN VIVO	HARRINGTONINE	.

Unknown organism

Experiment #	Pharmacology Type	Worktypes	Compound	Results
1	PROTEIN SYNTHESIS INHIBITION	PHARMACOLOGY OF COMPOUND - IN VIVO	HARRINGTONINE,HOMO:	ACTIVE
2	PROTEIN SYNTHESIS INHIBITION	PHARMACOLOGY OF COMPOUND - IN VIVO	HARRINGTONINE,HOMO:	ACTIVE
3	TOXICITY ASSESSMENT(QUANTITATIVE)	TOXICITY MARKER CODEPHARMACOLOGY OF COMPOUND - IN VIVO	HARRINGTONINE,HOMO:	.
4	ANTITUMOR ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VIVOANTICANCER AND/OR CYTOTOXICITY MARKER CODE	HARRINGTONINE,HOMO:	INACTIVE
5	ANTITUMOR ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VIVOANTICANCER AND/OR CYTOTOXICITY MARKER CODE	HARRINGTONINE,HOMO:	INACTIVE
6	ANTITUMOR ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VIVOANTICANCER AND/OR CYTOTOXICITY MARKER CODE	HARRINGTONINE,HOMO:	ACTIVE

Unknown organism

Experiment #	Pharmacology Type	Worktypes	Compound	Results
1	PROTEIN SYNTHESIS INHIBITION	PHARMACOLOGY OF COMPOUND - IN VIVO	HARRINGTONINE,ISO:	ACTIVE
2	PROTEIN SYNTHESIS INHIBITION	PHARMACOLOGY OF COMPOUND - IN VIVO	HARRINGTONINE,ISO:	ACTIVE
3	TOXICITY ASSESSMENT(QUANTITATIVE)	TOXICITY MARKER CODEPHARMACOLOGY OF COMPOUND - IN VIVO	HARRINGTONINE,ISO:	.
4	ANTITUMOR ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VIVOANTICANCER AND/OR CYTOTOXICITY MARKER CODE	HARRINGTONINE,ISO:	INACTIVE
5	ANTITUMOR ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VIVOANTICANCER AND/OR CYTOTOXICITY MARKER CODE	HARRINGTONINE,ISO:	INACTIVE
6	ANTITUMOR ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VIVOANTICANCER AND/OR CYTOTOXICITY MARKER CODE	HARRINGTONINE,ISO:	INACTIVE

Unknown organism

Experiment #	Pharmacology Type	Worktypes	Compound	Results
1	PROTEIN SYNTHESIS INHIBITION	PHARMACOLOGY OF COMPOUND - IN VIVO	HARRINGTONINE,DEOXY:	ACTIVE
2	PROTEIN SYNTHESIS INHIBITION	PHARMACOLOGY OF COMPOUND - IN VIVO	HARRINGTONINE,DEOXY:	ACTIVE
3	TOXICITY ASSESSMENT(QUANTITATIVE)	TOXICITY MARKER CODEPHARMACOLOGY OF COMPOUND - IN VIVO	HARRINGTONINE,DEOXY:	.
4	ANTITUMOR ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VIVOANTICANCER AND/OR CYTOTOXICITY MARKER CODE	HARRINGTONINE,DEOXY:	INACTIVE
5	ANTITUMOR ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VIVOANTICANCER AND/OR CYTOTOXICITY MARKER CODE	HARRINGTONINE,DEOXY:	INACTIVE
6	ANTITUMOR ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VIVOANTICANCER AND/OR CYTOTOXICITY MARKER CODE	HARRINGTONINE,DEOXY:	INACTIVE

Show SPARQL Queries (1)